metricas
covid
Annals of Hepatology Most cited
Journal Information

Most cited

Data available in articles published since the year 2014

41
Diagnostic accuracy of blood biomarkers and non-invasive scores for the diagnosis of NAFLD and NASH: Systematic review and meta-analysis
Daniela Contreras, Alejandra González-Rocha, Patricia Clark, Simón Barquera, Edgar Denova-Gutiérrez
Ann Hepatol. 2023;28:100873
41
Open access
38
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis
Mark Muthiah, Cheng Han Ng, Kai En Chan, Clarissa Elysia Fu, Wen Hui Lim, Darren Jun Hao Tan, Benjamin Nah, Gwyneth Kong, ... Mazen Noureddin
Ann Hepatol. 2023;28:100762
38
Open access
35
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study
Ke Su, Qiuni Shen, Jian Tong, Tao Gu, Ke Xu, Han Li, Hao Chi, Yanlin Liu, ... Yunwei Han
Ann Hepatol. 2023;28:101109
35
Full text access
26
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network
Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, ... Jose D. Debes
Ann Hepatol. 2023;28:100876
26
Full text access
25
Abdominal obesity, chronic inflammation and the risk of non-alcoholic fatty liver disease
Dongna Zhao, Haozhe Cui, Zhiqiang Shao, Liying Cao
Ann Hepatol. 2023;28:100726
25
Full text access
25
Metabolic dysfunction: The silenced connection with fatty liver disease
Mariana M. Ramírez-Mejía, Xingshun Qi, Ludovico Abenavoli, Manuel Romero-Gómez, Mohammed Eslam, Nahum Méndez-Sánchez
Ann Hepatol. 2023;28:101138
25
Full text access
21
Elevated lactate/albumin ratio as a novel predictor of in-hospital mortality in hospitalized cirrhotics
Itamar Krispin, Mahmud Mahamid, Eran Goldin, Bashar Fteiha
Ann Hepatol. 2023;28:100897
21
Full text access
21
Oral 24-week probiotics supplementation did not decrease cardiovascular risk markers in patients with biopsy proven NASH: A double-blind placebo-controlled randomized study
Samantha Thifani Alrutz Barcelos, Amanda Souza Silva-Sperb, Helena Abadie Moraes, Larisse Longo, Bruna Concheski de Moura, Matheus Truccolo Michalczuk, Carolina Uribe-Cruz, Carlos Thadeu Schmidt Cerski, ... Mário Reis Álvares-da-Silva
Ann Hepatol. 2023;28:100769
21
Open access
20
Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action
Alexis Jose-Abrego, Ingrid Rivera-Iñiguez, Luis A. Torres-Reyes, Sonia Roman
Ann Hepatol. 2023;28:100766
20
Full text access
17
Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016
Zhenfei Chi, Yun Teng, Yuting Liu, Lu Gao, Junhan Yang, Zhe Zhang
Ann Hepatol. 2023;28:101125
17
Full text access